A detailed history of Mariner, LLC transactions in Danaher Corp stock. As of the latest transaction made, Mariner, LLC holds 228,650 shares of DHR stock, worth $53.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
228,650
Previous 226,417 0.99%
Holding current value
$53.7 Million
Previous $56.6 Million 12.36%
% of portfolio
0.11%
Previous 0.11%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$239.25 - $280.76 $534,245 - $626,937
2,233 Added 0.99%
228,650 $63.6 Million
Q2 2024

Aug 13, 2024

SELL
$235.51 - $267.98 $110,218 - $125,414
-468 Reduced 0.21%
226,417 $56.6 Million
Q1 2024

May 15, 2024

SELL
$224.58 - $256.19 $11.4 Million - $13 Million
-50,730 Reduced 18.27%
226,885 $56.7 Million
Q4 2023

Feb 14, 2024

SELL
$185.1 - $233.13 $67.3 Million - $84.7 Million
-363,360 Reduced 56.69%
277,615 $64.2 Million
Q3 2023

Nov 13, 2023

BUY
$233.08 - $265.59 $11.1 Million - $12.6 Million
47,430 Added 7.99%
640,975 $159 Million
Q2 2023

Aug 11, 2023

BUY
$224.99 - $256.14 $5.01 Million - $5.7 Million
22,262 Added 3.9%
593,545 $142 Million
Q1 2023

May 12, 2023

BUY
$239.75 - $277.0 $18.3 Million - $21.1 Million
76,235 Added 15.4%
571,283 $144 Million
Q4 2022

Feb 14, 2023

BUY
$241.42 - $282.29 $5.06 Million - $5.92 Million
20,975 Added 4.42%
495,048 $131 Million
Q3 2022

Nov 10, 2022

BUY
$247.06 - $1507.4 $6.95 Million - $42.4 Million
28,137 Added 6.31%
474,073 $122 Million
Q2 2022

Aug 15, 2022

BUY
$237.11 - $299.66 $12.3 Million - $15.6 Million
52,001 Added 13.2%
445,936 $113 Million
Q1 2022

May 13, 2022

BUY
$257.27 - $315.76 $15.3 Million - $18.8 Million
59,607 Added 17.83%
393,935 $116 Million
Q4 2021

Feb 14, 2022

BUY
$292.08 - $329.01 $23.3 Million - $26.3 Million
79,865 Added 31.39%
334,328 $110 Million
Q3 2021

Nov 15, 2021

BUY
$272.21 - $332.43 $4.34 Million - $5.3 Million
15,952 Added 6.69%
254,463 $77.5 Million
Q2 2021

Aug 24, 2021

BUY
$225.08 - $271.69 $3.08 Million - $3.71 Million
13,666 Added 6.08%
238,511 $64 Million
Q1 2021

May 07, 2021

BUY
$212.38 - $245.9 $5.63 Million - $6.52 Million
26,525 Added 13.37%
224,845 $50.6 Million
Q4 2020

Feb 16, 2021

BUY
$212.5 - $245.46 $5.84 Million - $6.74 Million
27,476 Added 16.08%
198,320 $44.1 Million
Q3 2020

Nov 13, 2020

BUY
$177.16 - $215.33 $2.19 Million - $2.66 Million
12,366 Added 7.8%
170,844 $36.8 Million
Q2 2020

Aug 14, 2020

BUY
$128.7 - $176.83 $2.81 Million - $3.86 Million
21,804 Added 15.95%
158,478 $28 Million
Q1 2020

May 14, 2020

BUY
$121.39 - $169.05 $5.28 Million - $7.35 Million
43,474 Added 46.65%
136,674 $18.9 Million
Q4 2019

Feb 13, 2020

BUY
$133.47 - $153.48 $26,694 - $30,695
200 Added 0.22%
93,200 $14.3 Million
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $49,150 - $53,168
-363 Reduced 0.39%
93,000 $13.4 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $173,333 - $199,497
1,388 Added 1.51%
93,363 $13.3 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $7.26 Million - $9.84 Million
74,371 Added 422.47%
91,975 $2.48 Million
Q4 2018

Feb 13, 2019

BUY
$94.85 - $109.54 $672,012 - $776,090
7,085 Added 67.35%
17,604 $1.81 Million
Q3 2018

Nov 14, 2018

BUY
$98.13 - $108.9 $62,508 - $69,369
637 Added 6.45%
10,519 $1.14 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $140,786 - $151,246
1,465 Added 17.41%
9,882 $975,000
Q1 2018

May 15, 2018

BUY
$92.16 - $103.8 $61,009 - $68,715
662 Added 8.54%
8,417 $824,000
Q4 2017

Feb 09, 2018

SELL
$85.26 - $94.62 $153,809 - $170,694
-1,804 Reduced 18.87%
7,755 $720,000
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $757,933 - $845,493
9,559
9,559 $820,000

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $171B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.